488
Views
14
CrossRef citations to date
0
Altmetric
Special review series

Novel antiplatelet targets in the treatment of acute coronary syndromes

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Qiqi Feng, Mengyang Wang, Eldar Muhtar, Yaonan Wang & Haimei Zhu. (2021) Nanoparticles of a New Small-Molecule P-Selectin Inhibitor Attenuate Thrombosis, Inflammation, and Tumor Growth in Two Animal Models. International Journal of Nanomedicine 16, pages 5777-5795.
Read now
Steven G. Chrysant & George S. Chrysant. (2020) New and emerging cardiovascular and antihypertensive drugs. Expert Opinion on Drug Safety 19:10, pages 1315-1327.
Read now

Articles from other publishers (11)

Constance C F M J Baaten, Magdolna Nagy, Wolfgang Bergmeier, Henri M H Spronk & Paola E J van der Meijden. (2023) Platelet biology and function: plaque erosion vs. rupture. European Heart Journal.
Crossref
Fawaz O. Alenazy, Maan H. Harbi, Dean P. Kavanagh, Joshua Price, Paul Brady, Oscar Hargreaves, Paul Harrison, Alexandre Slater, Alok Tiwari, Phillip L.R. Nicolson, Derek L. Connolly, Paulus Kirchhof, Neena Kalia, Martine Jandrot-Perrus, Pierre H. Mangin, Steve P. Watson & Mark R. Thomas. (2023) Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy. Journal of Thrombosis and Haemostasis 21:11, pages 3236-3251.
Crossref
Yijie Yang, Qi Tian, Shiming Li & Bo Li. (2023) Structural Insights on Hyp-Gly-Containing Peptides as Antiplatelet Compounds through Topomer CoMFA and CoMSIA Analysis. Foods 12:4, pages 777.
Crossref
Sujuan LiWeili WangLisha Lin, Lian YangYing CaiXingzhi YangTaocui ZhangChuang XiaoHui YanNa GaoJinhua Zhao. (2023) Oligosaccharide Blocks PAR1 (Proteinase-Activated Receptor 1)-PAR4–Mediated Platelet Activation by Binding to Thrombin Exosite II and Impairs Thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 43:2, pages 253-266.
Crossref
Hongdan Wang, Bingyu Zhang, Xianhua Zhong, Dui Qin & Zhangyong Li. (2023) Mechanism Research of Platelet Core Marker Prediction and Molecular Recognition in Cardiovascular Events. Combinatorial Chemistry & High Throughput Screening 26:1, pages 103-115.
Crossref
Hanne Berg Ravn & Henrik Schmidt. 2023. Cardiopulmonary Bypass. Cardiopulmonary Bypass 927 936 .
Christopher W. Smith, Maan H. Harbi, Lourdes Garcia‐Quintanilla, Kieran Rookes, Helena Brown, Natalie S. Poulter, Steve P. Watson, Phillip L.R. Nicolson & Mark R. Thomas. (2022) The Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity. Journal of Thrombosis and Haemostasis 20:12, pages 2939-2952.
Crossref
Ignacio Barriuso, Fernando Worner & Gemma Vilahur. (2022) Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment. Journal of Cardiovascular Development and Disease 9:11, pages 397.
Crossref
E. Scott Priestley, Jacques Banville, Daniel Deon, Laurence Dubé, Marc Gagnon, Julia Guy, Philippe Lapointe, Jean-François Lavallée, Alain Martel, Serge Plamondon, Roger Rémillard, Edward Ruediger, François Tremblay, Shana L. Posy, Victor R. Guarino, Jeremy M. Richter, Jianqing Li, Anuradha Gupta, Muthalagu Vetrichelvan, T. J. Balapragalathan, Arvind Mathur, Ji Hua, Mario Callejo, Jocelyne Guay, Chi Shing Sum, Mary Ellen Cvijic, Carol Watson, Pancras Wong, Jing Yang, Michel Bouvier, David A. Gordon, Ruth R. Wexler & Anne Marinier. (2022) Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4. Journal of Medicinal Chemistry 65:13, pages 8843-8854.
Crossref
Oliver Buchhave Pedersen, Leonardo Pasalic, Peter H. Nissen, Erik Lerkevang Grove, Steen Dalby Kristensen & Anne-Mette Hvas. (2022) Flow Cytometric Assessment of Changes in Platelet Reactivity after Acute Coronary Syndrome: A Systematic Review. Seminars in Thrombosis and Hemostasis 48:05, pages 542-551.
Crossref
Peixun He, Xiaolin Luo, Jiabei Li, Yi Li, Xiaozeng Wang, Lan Huang, Jun Jin & Yaling Han. (2021) Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes. Cardiovascular Therapeutics 2021, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.